Difficulty: Medium
Average Score: 85%
Practice
These drugs may be used in the treatment of recurrent calcium nephrolithiasis:
Correct answer
C
Rationale
In the treatment of recurrent calcium nephrolithiasis, thiazide diuretics (Option C) are used due to their ability to reduce calcium excretion in the urine, thus helping to prevent the formation of calcium stones. Thiazide diuretics work by enhancing calcium reabsorption in the kidneys, leading to decreased urinary calcium levels.
Option A, osmotic diuretics, are not typically used in the treatment of calcium nephrolithiasis as they primarily act by increasing urine volume without affecting calcium levels. Loop diuretics (Option B) are also not the preferred choice for calcium nephrolithiasis as they primarily impact sodium and potassium excretion, but not calcium. Potassium-sparing diuretics (Option D) are not recommended for treating calcium nephrolithiasis as they may actually increase urinary calcium levels.
In an educational context, understanding the specific mechanisms of action of different diuretics and their implications in various clinical conditions is crucial for healthcare professionals, especially pharmacists and physicians, involved in managing patients with recurrent calcium nephrolithiasis. This knowledge helps in making informed decisions regarding the most appropriate pharmacological interventions for optimal patient outcomes.
Option A, osmotic diuretics, are not typically used in the treatment of calcium nephrolithiasis as they primarily act by increasing urine volume without affecting calcium levels. Loop diuretics (Option B) are also not the preferred choice for calcium nephrolithiasis as they primarily impact sodium and potassium excretion, but not calcium. Potassium-sparing diuretics (Option D) are not recommended for treating calcium nephrolithiasis as they may actually increase urinary calcium levels.
In an educational context, understanding the specific mechanisms of action of different diuretics and their implications in various clinical conditions is crucial for healthcare professionals, especially pharmacists and physicians, involved in managing patients with recurrent calcium nephrolithiasis. This knowledge helps in making informed decisions regarding the most appropriate pharmacological interventions for optimal patient outcomes.